keyword
Keywords hypertension randomized contro...

hypertension randomized controlled trial 2016

https://read.qxmd.com/read/38699077/differential-effect-by-chronic-disease-risk-a-secondary-analysis-of-the-choosewell-365-randomized-controlled-trial
#1
JOURNAL ARTICLE
J Cheng, D E Levy, J L McCurley, E B Rimm, E D Gelsomin, A N Thorndike
OBJECTIVE: Whether employees' health status is associated with the effectiveness of workplace health promotion programs is unknown. The objective of this study was to determine if the effect of a workplace healthy eating intervention differed by baseline chronic disease status. METHODS: This was a secondary analysis of a randomized controlled trial conducted September 2016 to February 2018 among US hospital employees to test the effect of a 12-month behavioral intervention (personalized feedback, peer comparisons, and financial incentives) on diet and weight...
June 2024: Preventive Medicine Reports
https://read.qxmd.com/read/38591664/inhaled-bronchodilators-for-the-prevention-and-treatment-of-chronic-lung-disease-in-preterm-infants
#2
REVIEW
Geraldine Ng, Matteo Bruschettini, John Ibrahim, Orlando da Silva
BACKGROUND: Chronic lung disease (CLD) occurs frequently in preterm infants and is associated with respiratory morbidity. Bronchodilators have the potential effect of dilating small airways with muscle hypertrophy. Increased compliance and tidal volume, and decreased airway resistance, have been documented with the use of bronchodilators in infants with CLD. Therefore, bronchodilators are widely considered to have a role in the prevention and treatment of CLD, but there remains uncertainty as to whether they improve clinical outcomes...
April 9, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38548406/macitentan-for-the-treatment-of-inoperable-chronic-thromboembolic-pulmonary-hypertension-merit-1-results-from-the-multicentre-phase-2-randomised-double-blind-placebo-controlled-study
#3
RANDOMIZED CONTROLLED TRIAL
Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, Peter Fedullo, Luke S Howard, Xavier Jaïs, David P Jenkins, Zhi-Cheng Jing, Michael M Madani, Nicolas Martin, Eckhard Mayer, Kelly Papadakis, Dominik Richard, Nick H Kim
BACKGROUND: Macitentan is beneficial for long-term treatment of pulmonary arterial hypertension. The microvasculopathy of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension are similar. METHODS: The phase 2, double-blind, randomised, placebo-controlled MERIT-1 trial assessed macitentan in 80 patients with CTEPH adjudicated as inoperable. Patients identified as WHO functional class II-IV with a pulmonary vascular resistance (PVR) of at least 400 dyn·s/cm5 and a walk distance of 150-450 m in 6 min were randomly assigned (1:1), via an interactive voice/web response system, to receive oral macitentan (10 mg once a day) or placebo...
April 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38516265/efficacy-of-ehealth-interventions-to-reduce-depression-symptoms-in-individuals-with-obesity-a-systematic-review-of-randomized-controlled-trials
#4
Dilara Kocol, Alexander Bäuerle, Theresa Schadendorf, Sheila Geiger, Julia Barbara Krakowczyk, Eva-Maria Skoda, Martin Teufel
INTRODUCTION: Obesity and depression are inter-related health concerns, demanding a high level of treatment and costs in the health care system. The development of eHealth interventions that simultaneously address obesity and mental health can be supportive in this regard. However, evidence of the efficacy of eHealth interventions in the treatment of depression symptoms in individuals with obesity is lacking. The aim of this systematic literature review is to evaluate the efficacy of existing eHealth interventions for individuals with obesity that target depression symptoms...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38514585/future-perspectives-of-pulmonary-arterial-hypertension-a-review-of-novel-pipeline-treatments-and-indications
#5
REVIEW
Maria Eugenia Novara, Enrica Di Martino, Brandon Stephens, Mary Nayrouz, Patrizio Vitulo, Anna Carollo, Alessio Provenzani
Pulmonary arterial hypertension is characterized by elevated blood pressure and pathological changes in the pulmonary arterioles, leading to the development of right-heart failure and potentially fatal outcomes if left untreated. This review aims to provide an overview of novel drugs or formulations and new drug indications for pulmonary arterial hypertension that are currently in phases II-III of randomized controlled trials, and describe the rationale for the use of these targeted therapies, as well as their efficacy, safety profile, and impact on quality of life and survival...
March 22, 2024: Drugs in R&D
https://read.qxmd.com/read/38497987/practice-facilitation-and-peer-coaching-for-uncontrolled-hypertension-among-black-individuals-a-randomized-clinical-trial
#6
JOURNAL ARTICLE
Monika M Safford, Doyle M Cummings, Jacqueline R Halladay, James M Shikany, Joshua Richman, Suzanne Oparil, James Hollenberg, Alyssa Adams, Muna Anabtawi, Lynn Andreae, Elizabeth Baquero, Joanna Bryan, Debra Sanders-Clark, Ethel Johnson, Erica Richman, Orysya Soroka, Jimmy Tillman, Andrea L Cherrington
IMPORTANCE: Rural Black participants need effective intervention to achieve better blood pressure (BP) control. OBJECTIVE: Among Black rural adults with persistently uncontrolled hypertension attending primary care clinics, to determine whether peer coaching (PC), practice facilitation (PF), or both (PCPF) are superior to enhanced usual care (EUC) in improving BP control. DESIGN, SETTING, AND PARTICIPANTS: A cluster randomized clinical trial was conducted in 69 rural primary care practices across Alabama and North Carolina between September 23, 2016, and September 26, 2019...
March 18, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38273643/statin-use-in-cirrhosis-and-its-association-with-incidence-of-portal-vein-thrombosis
#7
JOURNAL ARTICLE
Waseem Amjad, Zhenghui Jiang, Michelle Lai
BACKGROUND AND AIM: Statin use has shown a reduction in hepatic decompensation and portal hypertension. Its association with portal vein thrombosis (PVT) incidence is unknown. We aim to compare the incidence of PVT in patients with and without statin use. METHODS: We excluded patients with a history of hepatocellular cancer, liver transplants, Budd-Chiari syndrome, and intra-abdominal malignancies. Patients with cirrhosis were followed from their first hepatologist clinical encounter (January 1, 2016, to January 31, 2021) for 180 days to determine PVT incidence...
January 25, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38101983/cabozantinib-in-the-routine-management-of-renal-cell-carcinoma-a-systematic-literature-review-of-real-world-evidence
#8
REVIEW
Marine Gross-Goupil, Lubomir Bodnar, Matthew T Campbell, Agnieszka Michael, Balaji Venugopal, Jakub Żołnierek, Pascale Dutailly, Giuseppe Procopio, Laurence Albiges
Real-world cabozantinib use has increased since its approval to treat patients with advanced renal cell carcinoma (RCC) in 2016. We reviewed cabozantinib use in real-world clinical practice and compared outcomes with pivotal cabozantinib randomized control trials (RCTs). This PRISMA-standard systematic literature review evaluated real-world effectiveness and tolerability of cabozantinib in patients with RCC (PROSPERO registration: CRD42021245854). Systematic MEDLINE, Embase, and Cochrane database searches were conducted on November 2, 2022...
February 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38060092/efficacy-and-safety-of-the-travoprost-intraocular-implant-in-reducing-topical-iop-lowering-medication-burden-in-patients-with-open-angle-glaucoma-or-ocular-hypertension
#9
JOURNAL ARTICLE
John P Berdahl, Steven R Sarkisian, Robert E Ang, Long V Doan, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil
PURPOSE: A randomized, double-masked, multicenter, phase 2 trial to evaluate the long-term safety and efficacy of travoprost intraocular implant, an extended-release drug delivery system designed to provide uninterrupted sustained intraocular pressure (IOP)-lowering therapy, thereby reducing patient treatment burden and improving adherence with IOP-lowering medication. METHODS: Patients with open-angle glaucoma or ocular hypertension were administered a fast-eluting implant (FE implant, n = 51) and received twice-daily (BID) placebo eye drops, a slow-eluting (SE implant, n = 54) and received BID placebo eye drops, or underwent a sham surgical procedure and received BID timolol 0...
December 7, 2023: Drugs
https://read.qxmd.com/read/38023239/apatinib-plus-chemotherapy-for-non-metastatic-osteosarcoma-a-retrospective-cohort-study
#10
JOURNAL ARTICLE
Jiaqiang Wang, Fan Zhang, Shuping Dong, Yang Yang, Fangfang Gao, Guancong Liu, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian
BACKGROUND: Effective adjuvant therapy for osteosarcoma is necessary for improved outcomes. Previous studies demonstrated that apatinib plus doxorubicin-based chemotherapy may improve the efficacy of neoadjuvant therapy. This study aimed to clarify the effectiveness and safety of apatinib plus doxorubicin and cisplatin (AP) as neoadjuvant therapy for osteosarcoma. METHODS: The clinical data of osteosarcoma patients who underwent neoadjuvant therapy and surgery between August 2016 and April 2022 were retrospectively collected and analyzed...
2023: Frontiers in Oncology
https://read.qxmd.com/read/38004331/influence-of-the-dash-diet-on-gestational-weight-gain-and-perinatal-outcomes-in-women-with-pre-existing-diabetes-mellitus-a-randomized-single-blind-controlled-clinical-trial
#11
JOURNAL ARTICLE
Gabriella P Belfort, Dayana R Farias, Patricia de C Padilha, Letícia B G da Silva, Karina Dos Santos, Mayara S Dos Santos, Lenita Zajdenverg, Elisa Keating, Claudia Saunders
BACKGROUND: This study aimed to investigate the influence of the dietary approaches to stop hypertension (DASH) diet on gestational weight gain and perinatal outcomes in pregnant women with pre-existing diabetes mellitus (PDM). METHODS: A randomized, single-blind, controlled clinical trial was conducted with 68 pregnant women with PDM throughout prenatal care until delivery (18 weeks) at a public maternity hospital in Rio de Janeiro, Brazil (2016-2020). The standard diet adopted by the control group (standard diet group-SDG) contained 45-55% carbohydrates, 15-20% protein, and 25-30% lipids of the total energy intake...
November 10, 2023: Life
https://read.qxmd.com/read/37815094/different-intensities-of-glycaemic-control-for-women-with-gestational-diabetes-mellitus
#12
REVIEW
Olivia J Hofer, Ruth Martis, Jane Alsweiler, Caroline A Crowther
BACKGROUND: Gestational diabetes mellitus (GDM) has major short- and long-term implications for both the mother and her baby. GDM is defined as a carbohydrate intolerance resulting in hyperglycaemia or any degree of glucose intolerance with onset or first recognition during pregnancy from 24 weeks' gestation onwards and which resolves following the birth of the baby. Rates for GDM can be as high as 25% depending on the population and diagnostic criteria used, and overall rates are increasing globally...
October 10, 2023: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/37747734/a-multifaceted-implementation-strategy-to-increase-out-of-office-blood-pressure-monitoring-the-embrace-cluster-randomized-clinical-trial
#13
JOURNAL ARTICLE
Ian M Kronish, Erica Phillips, Carmela Alcántara, Eileen Carter, Joseph E Schwartz, Daichi Shimbo, Maria Serafini, Rebekah Boyd, Melinda Chang, Xiaohui Wang, Dominic Razon, Akash Patel, Nathalie Moise
IMPORTANCE: Few primary care patients complete guideline-recommended out-of-office blood pressure (BP) monitoring prior to having hypertension diagnosed. OBJECTIVE: To evaluate the effectiveness of a behavioral theory-informed, multifaceted implementation strategy on out-of-office BP monitoring (ambulatory BP monitoring [ABPM] or home BP monitoring [HBPM]) among patients with new hypertension. DESIGN, SETTING, AND PARTICIPANTS: This 2-group, pre-post cluster randomized trial was conducted within a primary care network of 8 practices (4 intervention practices with 99 clinicians; 4 control practices with 55 clinicians) and 1186 patients (857 intervention; 329 control) with at least 1 visit with elevated office BP and no prior hypertension diagnosis between October 2016 and September 2017 (preimplementation period) or between April 2018 and March 2019 (postimplementation period)...
September 5, 2023: JAMA Network Open
https://read.qxmd.com/read/37486372/partial-splenic-embolization-combined-with-endoscopic-therapies-and-vasoconstrictive-drugs-reduces-rebleeding-in-cirrhosis-patients-with-acute-variceal-bleeding-and-hypersplenism-a-multicenter-randomized-controlled-trial
#14
JOURNAL ARTICLE
Min Wei, Yong Chen, Minghui Wang, Jinhou Li, Yunqing Zeng, Xin Sun, Anzhong Zhang, Xiaofeng Liu, Tao Zhou, Yanjing Gao
BACKGROUND: This study aimed to compare the efficacy of partial splenic embolization (PSE) combined with endoscopic therapy and endoscopic therapy alone in cirrhosis patients with acute variceal bleeding (AVB) and hypersplenism. METHODS: Cirrhosis patients with AVB who visited three hospitals from June 2016 to June 2022 were prospectively enrolled and randomly allocated to either the endoscopic therapy combined with PSE group (EP group) or the endoscopic intervention group (E group) in a 1:1 ratio...
July 24, 2023: Journal of Gastroenterology
https://read.qxmd.com/read/37448249/-semaglutide-effectiveness-in-weight-loss-and-side-effects-when-used-according-to-studies-by-sustain-pioneer-step
#15
REVIEW
O R Shabutdinova, A R Dautov, A A Samkov, A V Kononenko, A F Sargaliev, A R Davletshin, P A Andresova, K R Zarbeeva, D A Torshkhoeva, U A Rakhmonkulov, A A Afanasyev
Overweight and obesity are a worldwide common problem and are diagnosed with a body mass index (BMI) value in the range of 25.0-29.9 kg/m2 and ≥30.0 kg/m2, respectively. Obese patients are at high risk of developing concomitant diseases, such as hypertension, type 2 diabetes mellitus (DM2), hyperlipidemia, stroke and even some types of cancer. In the Russian Federation in 2016, the proportion of overweight people was 62.0%, with obesity - 26.2%. The authors performed an electronic search in the PubMed information database...
June 30, 2023: Problemy E̊ndokrinologii
https://read.qxmd.com/read/37257691/employees-baseline-food-choices-and-the-effect-of-a-workplace-intervention-to-promote-healthy-eating-secondary-analysis-of-the-choosewell-365-randomized-controlled-trial
#16
JOURNAL ARTICLE
Maggie Salinger, Douglas E Levy, Jessica L McCurley, Emily D Gelsomin, Eric B Rimm, Anne N Thorndike
BACKGROUND: Little is known about whether the effectiveness of workplace wellness programs differs by employees' baseline health behaviors. OBJECTIVE: This study examined the association of baseline cafeteria food choices with the effect of a workplace intervention on cafeteria food choices, dietary quality, and body mass index (BMI). DESIGN: This was a secondary analysis of the ChooseWell 365 randomized controlled trial testing a set of behavioral interventions to improve diet and prevent weight gain...
May 29, 2023: Journal of the Academy of Nutrition and Dietetics
https://read.qxmd.com/read/36990721/national-trends-of-cerebral-venous-sinus-stenting-for-the-treatment-of-idiopathic-intracranial-hypertension
#17
JOURNAL ARTICLE
Mihir Khunte, Huanwen Chen, Marco Colasurdo, Seemant Chaturvedi, Ajay Malhotra, Dheeraj Gandhi
BACKGROUND: Cerebral venous sinus stenting (VSS) has emerged as a new surgical procedure for the treatment of severe IIH, and its popularity has been anecdotally on the rise. This study explores recent temporal trends of VSS and other surgical IIH treatments in the United States. METHODS: Adult IIH patients were identified from the 2016-20 National Inpatient Sample databases, and surgical procedures and hospital characteristics were recorded. Temporal trends of procedure numbers for VSS, cerebrospinal fluid (CSF) shunts, and optic nerve sheath fenestrations (ONSF) were assessed and compared...
March 29, 2023: Neurology
https://read.qxmd.com/read/36938333/intermediate-hyperglycaemia-diabetes-and-blood-pressure-in-rural-bangladesh-five-year-post-randomisation-follow-up-of-the-dmagic-cluster-randomised-controlled-trial
#18
JOURNAL ARTICLE
Edward Fottrell, Carina King, Naveed Ahmed, Sanjit Kumer Shaha, Joanna Morrison, Malini Pires, Abdul Kuddus, Tasmin Nahar, Hassan Haghparast-Bidgoli, A K Azad Khan, Kishwar Azad
BACKGROUND: The DMagic trial showed that participatory learning and action (PLA) community mobilisation delivered through facilitated community groups, and mHealth voice messaging interventions improved diabetes knowledge in Bangladesh and the PLA intervention reduced diabetes occurrence. We assess intervention effects three years after intervention activities stopped. METHODS: Five years post-randomisation, we conducted a cross-sectional survey among a random sample of adults aged ≥30-years living in the 96 DMagic villages, and a cohort of individuals identified with intermediate hyperglycaemia at the start of the DMagic trial in 2016...
March 2023: Lancet Reg Health Southeast Asia
https://read.qxmd.com/read/36857053/association-of-intensive-vs-standard-blood-pressure-control-with-regional-changes-in-cerebral-small-vessel-disease-biomarkers-post-hoc-secondary-analysis-of-the-sprint-mind-randomized-clinical-trial
#19
JOURNAL ARTICLE
Tanweer Rashid, Karl Li, Jon B Toledo, Ilya Nasrallah, Nicholas M Pajewski, Sudipto Dolui, John Detre, David A Wolk, Hangfan Liu, Susan R Heckbert, R Nick Bryan, Jeff Williamson, Christos Davatzikos, Sudha Seshadri, Lenore J Launer, Mohamad Habes
IMPORTANCE: Little is known about the associations of strict blood pressure (BP) control with microstructural changes in small vessel disease markers. OBJECTIVE: To investigate the regional associations of intensive vs standard BP control with small vessel disease biomarkers, such as white matter lesions (WMLs), fractional anisotropy (FA), mean diffusivity (MD), and cerebral blood flow (CBF). DESIGN, SETTING, AND PARTICIPANTS: The Systolic Blood Pressure Intervention Trial (SPRINT) is a multicenter randomized clinical trial that compared intensive systolic BP (SBP) control (SBP target <120 mm Hg) vs standard control (SBP target <140 mm Hg) among participants aged 50 years or older with hypertension and without diabetes or a history of stroke...
March 1, 2023: JAMA Network Open
https://read.qxmd.com/read/36790817/prevalence-and-prognostic-significance-of-bradyarrhythmias-in-patients-screened-for-atrial-fibrillation-vs-usual-care-post-hoc-analysis-of-the-loop-randomized-clinical-trial
#20
JOURNAL ARTICLE
Søren Zöga Diederichsen, Lucas Yixi Xing, Diana My Frodi, Emilie Katrine Kongebro, Ketil Jørgen Haugan, Claus Graff, Søren Højberg, Derk Krieger, Axel Brandes, Lars Køber, Jesper Hastrup Svendsen
IMPORTANCE: There is increasing interest in heart rhythm monitoring and technologies to detect subclinical atrial fibrillation (AF), which may lead to incidental diagnosis of bradyarrhythmias. OBJECTIVE: To assess bradyarrhythmia prevalence and prognostic significance in persons screened for AF using implantable loop recorder (ILR) compared with unscreened persons. DESIGN, SETTING, AND PARTICIPANTS: This was a post hoc analysis of the Implantable Loop Recorder Detection of Atrial Fibrillation to Prevent Stroke (LOOP) randomized clinical trial, which took place in 4 sites in Denmark...
April 1, 2023: JAMA Cardiology
keyword
keyword
89425
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.